Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke

NCT05046106 is registered in ClinicalTrials.gov with Moleac Pte Ltd. as lead sponsor.

NCT NCT05046106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05046106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke
Lead sponsor
Moleac Pte Ltd.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
December 31, 2028
Enrollment
540 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, stroke sequelae, stroke, cardiovascular, stroke, cryptogenic, stroke, embolic, stroke, ischemic, strokes thrombotic